[对产前类固醇暴露与晚期早产新生儿低血糖之间的相关性进行元分析]
1Department of Neonatology, Shenzhen Children's Hospital, Shenzhen 518034, China.
Zhonghua er ke za zhi = Chinese journal of pediatrics
|June 14, 2023
概括
产前类固醇暴露会增加晚期早产新生儿低血糖的风险. 这次系统性审查和元分析发现了显著的相关性,突出了新生儿健康结果的潜在风险因素.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 晚期早产新生儿有各种并发症的风险增加.
- 产前类固醇暴露是高风险妊娠中常见的干预措施.
- 产前类固醇暴露与新生儿低血糖症之间的关联需要系统评估.
研究的目的:
- 系统地评估产前类固醇暴露与晚期早产新生儿低血糖之间的相关性.
- 利用元分析,综合来自多项研究的证据.
主要方法:
- 在八个主要数据库 (PubMed,Cochrane Library,Embase,Medline,Scopus,CNKI,Wanfang,VIP) 进行了全面的文献搜索,截至2022年12月.
- 包括的研究包括6项追溯队列研究,2项前性队列研究和1项随机对照试验 (RCT).
- 用Stata 14.0统计软件对9,143名婴儿的数据进行了元分析.
主要成果:
- 产前类固醇暴露与晚期早产新生儿低血糖症的风险增加有关 (RR=1.55,95% CI 1.25-1.91,P<0.001).
- 这种相关性在各种子组中是一致的,包括地理区域,孕妇疾病 (妊娠期糖尿病),文献质量,低血糖标准,样本大小,类固醇剂量/频率以及与分娩相比的施用时间.
- 后回归确定了类固醇注射频率和剂量作为异质性的重要来源.
结论:
- 产前类固醇暴露被确定为晚期早产新生儿低血糖的潜在危险因素.
- 这些发现强调了需要仔细考虑在临近期的孕妇中使用类固醇的必要性.
- 进一步的研究可能将重点放在优化类固醇治疗方案,以减轻新生儿低血糖风险.
相关概念视频
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


